Spruce Biosciences
SPRB
43 hedge funds and large institutions have $34.4M invested in Spruce Biosciences in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 50 → 43 (-7)
56% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 18
57% less capital invested
Capital invested by funds: $79M → $34.4M (-$44.6M)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$271K |
| 2 |
Bank of New York Mellon
New York
|
+$220K |
| 3 |
State Street
Boston,
Massachusetts
|
+$195K |
| 4 |
Renaissance Technologies
New York
|
+$178K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$90.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$542K |
| 2 |
Goldman Sachs
New York
|
-$467K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$318K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$267K |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$248K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LCM
51
Laurion Capital Management
New York
| – | -$51K | -151 | Closed |
|
52
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$7K | -20 | Closed |
|
|
CAL
53
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | -$1K | -3 | Closed |
|
|
EI
54
Ellevest Inc
New York
| – | -$1K | -2 | Closed |
|
SPRB Hedge Fund Activity: Q1 2022 in Review
43 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q1 2022, worth a combined $34.4M — down 57% from $79M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of SPRB and 4 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 8 added.
The largest buyer was BlackRock, adding an estimated $271K. The largest seller was Vanguard Group, cutting an estimated $542K.
- 43 institutional investors held Spruce Biosciences (SPRB) as of Q1 2022, down from 50 in Q4 2021.
- Funds reported $34.4M of Spruce Biosciences stock for Q1 2022, down 57% quarter-over-quarter.
- 4 funds opened new Spruce Biosciences positions in Q1 2022 and 11 closed out, a net change of -7 holders.
- The largest Spruce Biosciences buyer in Q1 2022 was BlackRock, an estimated $271K added.
- The largest Spruce Biosciences seller in Q1 2022 was Vanguard Group, an estimated $542K sold.
Based on aggregated 13F filings for Q1 2022.